SHOP's capital-light model, global diversification and margin gains put it ahead of MELI facing Latin America volatility.
This roundup highlights recent FDA updates related to drug approvals and devices used by optometric eye care professionals.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果